Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-09-30 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net revenue | 187,797,000 | 181,330,000 | 168,035,000 | 27,279,000 | 25,126,000 | 24,370,000 | 23,026,000 | 24,999,000 | 23,217,000 | 20,670,000 | 18,182,000 | 18,323,000 | 16,884,000 | 15,603,000 | 15,657,000 | 14,894,000 | 14,202,000 | 15,611,000 | 15,160,000 | 12,893,000 | 11,320,000 | 10,466,000 | 8,805,000 | 8,755,000 | 8,708,000 | 8,490,000 | 8,418,000 | 7,296,800 | 14,094,959 | 4,881,402 | 4,162,762 | |||||||||||||||||||||||||||||||||||||
cost of revenue | 107,351,000 | 104,072,000 | 94,789,000 | 94,743,000 | 92,944,000 | 92,008,000 | 90,771,000 | 87,964,000 | 89,643,000 | 87,026,000 | 82,406,000 | 81,880,000 | 79,889,000 | 81,126,000 | 78,937,000 | 80,475,000 | 74,101,000 | 68,734,000 | 73,959,000 | 68,544,000 | 71,379,000 | 58,971,000 | 59,661,000 | 56,945,000 | 53,840,000 | 52,747,000 | 48,462,000 | 39,365,000 | 36,775,000 | 37,216,000 | 36,120,000 | 34,661,000 | 34,242,000 | 34,912,000 | 34,480,000 | 33,233,000 | 33,416,000 | 34,524,000 | 32,531,000 | 15,051,000 | 13,955,000 | 13,557,000 | 13,482,000 | 13,529,000 | 12,923,000 | 10,431,000 | 9,473,000 | 9,160,000 | 8,713,000 | 8,446,000 | 8,411,000 | 8,460,000 | 8,310,000 | 8,244,000 | 8,016,000 | 7,060,000 | 6,246,000 | 5,810,000 | 4,940,000 | 4,851,000 | 4,818,000 | 4,575,000 | 4,344,000 | 3,672,289 | 6,577,549 | 2,183,758 | 1,858,474 | |
gross profit | 80,446,000 | 77,258,000 | 73,246,000 | 77,257,000 | 74,880,000 | 72,494,000 | 65,469,000 | 67,588,000 | 62,311,000 | 59,891,000 | 54,814,000 | 56,825,000 | 48,893,000 | 43,946,000 | 38,232,000 | 45,257,000 | 47,239,000 | 52,990,000 | 41,574,000 | 57,453,000 | 54,065,000 | 28,006,000 | 46,369,000 | 49,923,000 | 50,832,000 | 48,966,000 | 47,115,000 | 22,538,750 | 32,321,000 | 30,530,000 | 27,303,000 | 21,796,000 | 28,810,000 | 31,178,000 | 7,311,000 | 10,294,000 | 10,239,000 | 5,643,500 | 8,171,000 | 7,157,000 | 5,100,500 | 5,892,000 | 7,367,000 | 3,398,750 | 5,074,000 | 4,656,000 | 2,969,750 | 3,890,000 | 3,915,000 | 3,624,511 | 7,517,410 | 2,697,644 | 2,304,288 | |||||||||||||||
yoy | 7.43% | 6.57% | 11.88% | 14.31% | 20.17% | 21.04% | 19.44% | 18.94% | 27.44% | 36.28% | 43.37% | 25.56% | 3.50% | -17.07% | -8.04% | -21.23% | -12.63% | 89.21% | -10.34% | 15.08% | 6.36% | -42.81% | -1.58% | 121.50% | 57.27% | 60.39% | 72.56% | 3.41% | 12.19% | -2.08% | 29.55% | 25.98% | 43.06% | 10.65% | 38.68% | -2.85% | 50.07% | 16.12% | 58.23% | 14.45% | 30.44% | 18.93% | -18.06% | -47.92% | 57.29% | |||||||||||||||||||||||
qoq | 4.13% | 5.48% | -5.19% | 3.17% | 3.29% | 10.73% | -3.14% | 8.47% | 4.04% | 9.26% | -3.54% | 16.22% | 11.26% | 14.95% | -15.52% | -4.20% | -10.85% | 27.46% | -27.64% | 6.27% | 93.05% | -39.60% | -7.12% | -1.79% | 3.81% | 3.93% | 109.04% | -30.27% | 5.87% | 11.82% | 25.27% | -24.35% | -7.60% | -28.98% | 0.54% | -30.93% | 14.17% | -13.43% | -20.02% | -33.02% | 8.98% | -23.66% | -0.64% | 178.67% | 17.07% | |||||||||||||||||||||||
gross margin % | 63.25% | 44.62% | 44.07% | 41.90% | 43.45% | 41.01% | 40.77% | 39.95% | 40.97% | 37.97% | 35.14% | 32.63% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
general and administrative | 69,874,000 | 71,747,000 | 68,207,000 | 63,643,000 | 66,969,000 | 63,328,000 | 65,797,000 | 59,758,000 | 61,486,000 | 60,308,000 | 61,549,000 | 54,875,000 | 64,282,000 | 57,951,000 | 66,248,000 | 62,394,000 | 63,839,000 | 54,638,000 | 40,476,000 | 36,709,000 | 36,128,000 | 34,613,000 | 36,344,000 | 33,220,000 | 33,054,000 | 29,577,000 | 32,142,000 | 25,716,000 | 21,055,000 | 20,983,000 | 17,067,000 | 22,012,000 | 23,267,000 | 22,675,000 | 20,801,000 | 19,972,000 | 19,025,000 | 18,779,000 | 18,005,000 | 12,595,000 | 7,438,000 | 7,075,000 | 6,522,000 | 6,513,000 | 6,370,000 | 5,870,000 | 5,054,000 | 4,824,000 | 4,335,000 | 4,064,000 | 4,175,000 | 4,098,000 | 3,929,000 | 4,066,000 | 3,750,000 | 3,657,000 | 3,307,000 | 3,086,000 | 2,823,000 | 2,677,000 | 2,919,000 | 2,769,000 | 2,902,000 | 2,457,978 | 7,706,284 | 2,556,121 | 2,514,555 | |
research and development | 8,694,000 | 9,023,000 | 10,181,000 | 7,969,000 | 7,684,000 | 7,886,000 | 7,620,000 | 7,127,000 | 5,285,000 | 7,502,000 | 7,395,000 | 6,675,000 | 7,312,000 | 8,626,000 | 7,713,000 | 8,513,000 | 7,409,000 | 3,495,000 | 2,456,000 | 2,100,000 | 1,964,000 | 2,105,000 | 2,060,000 | 2,080,000 | 2,611,000 | 2,587,000 | 1,209,000 | 526,000 | 446,000 | 1,073,000 | 956,000 | 556,000 | 1,270,000 | 947,000 | 862,000 | 930,000 | 967,000 | 1,306,000 | 1,446,000 | 1,856,000 | 871,000 | 803,000 | 669,000 | 414,000 | 1,014,000 | 633,000 | 628,000 | 649,000 | 340,000 | 616,000 | 835,000 | 448,000 | 808,000 | 528,000 | 497,000 | |||||||||||||
sales and marketing | 21,806,000 | 24,075,000 | 22,683,000 | 22,339,000 | 20,415,000 | 21,677,000 | 20,221,000 | 18,072,000 | 17,610,000 | 18,901,000 | 16,259,000 | 17,142,000 | 16,809,000 | 17,071,000 | 16,299,000 | 15,917,000 | 15,704,000 | 17,224,000 | 13,749,000 | 13,105,000 | 11,304,000 | 10,195,000 | 13,258,000 | 12,302,000 | 11,508,000 | 12,324,000 | 11,216,000 | 8,047,000 | 6,900,000 | 7,680,000 | 6,775,000 | 6,077,000 | 6,577,000 | 6,242,000 | 5,648,000 | 5,826,000 | 5,958,000 | 6,327,000 | 5,800,000 | 2,993,000 | 2,748,000 | 2,907,000 | 2,914,000 | 3,224,000 | 2,983,000 | 3,158,000 | 2,633,000 | 2,487,000 | 2,336,000 | 1,972,000 | 1,931,000 | 1,692,000 | 1,839,000 | 1,934,000 | 2,036,000 | 1,801,000 | 1,725,000 | 1,684,000 | 1,753,000 | 1,790,000 | 1,983,000 | 1,943,000 | 1,763,000 | 1,792,955 | ||||
restructuring charges | 1,707,000 | 1,009,000 | 1,544,000 | 2,398,000 | 1,205,000 | 2,125,000 | 3,074,000 | 4,684,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment charges | 7,086,000 | 20,041,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total operating expenses | 107,460,000 | 124,886,000 | 101,071,000 | 95,658,000 | 96,077,000 | 94,435,000 | 96,036,000 | 86,162,000 | 86,506,000 | 89,785,000 | 89,887,000 | 83,208,000 | 88,403,000 | 83,648,000 | 90,260,000 | 86,824,000 | 86,952,000 | 75,357,000 | 56,681,000 | 51,914,000 | 49,396,000 | 46,913,000 | 51,662,000 | 47,602,000 | 47,173,000 | 44,488,000 | 44,567,000 | 34,289,000 | 28,401,000 | 29,736,000 | 24,798,000 | 28,645,000 | 32,172,000 | 29,864,000 | 27,311,000 | 30,192,000 | 25,950,000 | 26,412,000 | 25,251,000 | 17,444,000 | 11,057,000 | 10,785,000 | 10,105,000 | 10,151,000 | 10,367,000 | 9,661,000 | 8,315,000 | 7,960,000 | 7,011,000 | 6,652,000 | 6,941,000 | 6,238,000 | 6,576,000 | 6,528,000 | 6,283,000 | 3,594,750 | 5,032,000 | 4,770,000 | 4,576,000 | 3,569,750 | 4,902,000 | 4,712,000 | 4,665,000 | 4,379,816 | 7,905,620 | 2,625,367 | 2,569,651 | |
income from operations | -27,014,000 | -47,628,000 | -27,825,000 | -18,401,000 | -21,197,000 | -21,941,000 | -30,567,000 | -18,574,000 | -24,195,000 | -29,894,000 | -35,073,000 | -26,383,000 | -39,510,000 | -39,702,000 | -52,028,000 | -41,567,000 | -39,713,000 | -22,367,000 | -15,107,000 | 5,539,000 | 4,669,000 | -18,907,000 | -5,293,000 | 2,321,000 | 3,659,000 | 4,478,000 | 2,548,000 | 2,821,000 | 3,920,000 | 794,000 | 2,505,000 | 4,487,000 | -3,362,000 | 1,314,000 | -115,000 | -2,935,000 | 1,395,000 | 2,193,000 | 1,922,000 | -5,216,000 | 114,000 | 28,000 | -561,000 | 1,319,000 | -73,000 | 578,000 | 394,000 | 1,203,000 | 1,160,000 | 505,000 | 305,000 | 196,000 | -684,000 | 839,000 | 375,000 | 42,000 | -114,000 | -563,000 | -1,012,000 | -797,000 | ||||||||
yoy | 27.44% | 117.07% | -8.97% | -0.93% | -12.39% | -26.60% | -12.85% | -29.60% | -38.76% | -24.70% | -32.59% | -36.53% | -0.51% | 77.50% | 244.40% | -850.44% | -950.57% | 18.30% | 185.41% | 138.65% | 27.60% | -522.22% | -307.73% | -17.72% | -6.66% | 463.98% | 1.72% | -37.13% | -216.60% | -39.57% | -2278.26% | -252.88% | -341.00% | -40.08% | -105.98% | -43.73% | 1123.68% | 7732.14% | -442.60% | -495.45% | -256.16% | -95.16% | -242.39% | 9.64% | -106.29% | 14.46% | 29.18% | 513.78% | -269.59% | -39.81% | -47.73% | -1728.57% | -835.96% | -166.61% | -104.15% | -85.70% | ||||||||||||
qoq | -43.28% | 71.17% | 51.21% | -13.19% | -3.39% | -28.22% | 64.57% | -23.23% | -19.06% | -14.77% | 32.94% | -33.22% | -0.48% | -23.69% | 25.17% | 4.67% | 77.55% | 48.06% | -372.74% | 18.63% | -124.69% | 257.21% | -328.05% | -36.57% | -18.29% | 75.75% | -9.68% | -28.04% | 393.70% | -68.30% | -44.17% | -233.46% | -355.86% | -1242.61% | -96.08% | -310.39% | -36.39% | 14.10% | -136.85% | -4675.44% | 307.14% | -104.99% | -142.53% | -1906.85% | -112.63% | 46.70% | -67.25% | 3.71% | 129.70% | 65.57% | 55.61% | -128.65% | -181.53% | 792.86% | -136.84% | -44.37% | 26.98% | |||||||||||
operating margin % | -15.07% | -12.63% | -13.34% | -19.56% | -11.94% | -15.92% | -20.35% | -25.56% | -19.02% | -30.68% | -31.74% | -44.40% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest income | -1,563,000 | -2,263,000 | -3,721,000 | -4,328,000 | -4,673,000 | -4,592,000 | -4,834,000 | -10,071,000 | -2,840,000 | -2,524,000 | -1,467,000 | 1,301,000 | 128,883 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest expense | 603,000 | 933,000 | 1,618,000 | 1,624,000 | 1,642,000 | 1,666,000 | 1,685,000 | -860,000 | 139,000 | 926,000 | 1,707,000 | 1,296,000 | 902,000 | 1,177,000 | 2,194,000 | 2,458,000 | 1,548,000 | 819,000 | 380,000 | 203,000 | 1,304,000 | 1,826,000 | 1,191,500 | 1,873,000 | 1,407,000 | 1,486,000 | 1,043,250 | 1,398,000 | 1,411,000 | 1,364,000 | 1,127,250 | 1,468,000 | 1,448,000 | 1,593,000 | 199,336 | 69,246 | 55,096 | |||||||||||||||||||||||||||||||
other income | 335,000 | -482,000 | -65,000 | 431,000 | -317,000 | 2,000 | 263,000 | -124,000 | 96,000 | -730,000 | 114,000 | 1,000 | -25,000 | 405,000 | 930,000 | -89,000 | -171,000 | 4,854,000 | -4,222,000 | -11,000 | -7,405,000 | -223,000 | -494,000 | -35,000 | -10,000 | 5,169,000 | -45,000 | -30,000 | 124,000 | -63,000 | ||||||||||||||||||||||||||||||||||||||
income before taxes | -26,389,000 | -45,816,000 | -25,657,000 | -16,128,000 | -17,849,000 | -19,017,000 | -27,681,000 | -15,286,000 | -21,451,000 | -26,640,000 | -33,720,000 | -25,524,000 | -39,624,000 | -41,033,000 | -53,161,000 | -44,204,000 | -23,170,000 | 73,436,000 | -21,138,000 | 7,567,000 | 2,222,000 | -17,956,000 | -5,889,000 | 2,435,000 | 3,491,000 | 2,166,000 | -4,447,000 | 1,402,000 | 2,077,000 | -737,000 | 1,082,000 | -1,584,000 | -4,760,000 | -97,000 | -1,479,000 | -8,424,000 | -73,000 | 745,000 | 329,000 | 1,126,000 | -291,000 | 325,000 | 963,000 | 929,000 | 273,000 | |||||||||||||||||||||||
income tax benefit | 740,000 | -724,000 | 266,000 | -804,000 | -150,000 | -375,000 | -620,000 | -960,000 | -2,935,000 | -2,309,000 | -2,925,000 | -2,837,000 | -2,772,000 | -5,730,000 | -2,445,000 | -2,822,000 | -2,437,000 | 1,089,000 | -3,861,000 | 1,348,000 | 175,000 | 1,049,000 | 54,000 | -357,000 | 125,000 | -6,000 | ||||||||||||||||||||||||||||||||||||||||||
net income | -27,129,000 | -45,092,000 | -25,923,000 | -15,324,000 | -17,699,000 | -18,642,000 | -27,061,000 | -14,326,000 | -18,516,000 | -24,331,000 | -30,795,000 | -22,687,000 | -36,852,000 | -35,303,000 | -49,408,000 | -41,759,000 | -20,348,000 | 75,873,000 | -22,114,000 | 15,417,000 | 2,557,000 | -6,824,000 | -6,978,000 | 6,296,000 | 2,143,000 | 1,991,000 | -2,424,000 | 353,000 | 2,023,000 | -380,000 | 644,000 | -1,449,250 | -5,100,000 | -43,000 | -654,000 | -6,223,000 | -67,000 | 413,000 | 155,000 | -1,473,000 | -125,000 | -176,000 | -761,000 | 1,047,000 | -291,000 | 274,000 | 102,000 | 857,000 | 900,000 | 273,000 | 3,000 | -113,000 | -975,000 | 551,000 | 603,000 | 152,000 | -143,000 | -293,000 | -893,000 | -377,000 | -1,198,000 | -978,000 | -750,000 | -755,305 | -388,210 | 72,277 | -265,363 | |
yoy | 53.28% | 141.88% | -4.21% | 6.97% | -4.41% | -23.38% | -12.13% | -36.85% | -49.76% | -31.08% | -37.67% | -45.67% | 81.11% | -146.53% | 123.42% | -370.86% | -895.78% | -1211.86% | 216.91% | 144.87% | 19.32% | -442.74% | 187.87% | 1683.57% | 5.93% | -623.95% | -476.40% | -124.36% | -139.67% | 783.72% | -198.47% | -76.71% | 7511.94% | -110.41% | -521.94% | 322.47% | -46.40% | -334.66% | -120.37% | -240.69% | -57.04% | -164.23% | -846.08% | 22.17% | -132.33% | 0.37% | 3300.00% | -858.41% | -192.31% | -50.45% | -99.50% | -174.34% | 581.82% | -288.05% | -167.53% | -140.32% | -88.06% | -70.04% | 19.07% | -50.09% | 151.93% | -1137.67% | 184.63% | |||||
qoq | -39.84% | 73.95% | 69.17% | -13.42% | -5.06% | -31.11% | 88.89% | -22.63% | -23.90% | -20.99% | 35.74% | -38.44% | 4.39% | -28.55% | 18.32% | 105.22% | -126.82% | -443.10% | -243.44% | 502.93% | -137.47% | -2.21% | -210.83% | 193.79% | 7.63% | -182.14% | -786.69% | -82.55% | -632.37% | -159.01% | -144.44% | -71.58% | 11760.47% | -93.43% | -89.49% | 9188.06% | -116.22% | 166.45% | -110.52% | 1078.40% | -28.98% | -76.87% | -172.68% | -459.79% | -206.20% | 168.63% | -88.10% | -4.78% | 229.67% | 9000.00% | -102.65% | -88.41% | -276.95% | -8.62% | 296.71% | -206.29% | -51.19% | -67.19% | 136.87% | -68.53% | 22.49% | 30.40% | -0.70% | -637.11% | -127.24% | |||
net income margin % | -12.55% | -10.55% | -11.33% | -17.32% | -9.21% | -12.19% | -16.56% | -22.44% | -16.36% | -28.62% | -28.23% | -42.17% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | -0.005 | 0 | 0 | -0.01 | -0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | -0.21 | -0.35 | -0.2 | -0.12 | -0.14 | -0.15 | -0.21 | -0.11 | -0.15 | -0.19 | -0.25 | -0.18 | -0.3 | -0.28 | -0.4 | -0.35 | -0.17 | 0.64 | -0.19 | 0.14 | 0.02 | -0.06 | -0.07 | -0.03 | -0.043 | -0.1 | -0.03 | -0.04 | -0.053 | -0.07 | -0.07 | -0.07 | ||||||||||||||||||||||||||||||||||||
diluted | -0.21 | -0.35 | -0.2 | -0.12 | -0.14 | -0.15 | -0.21 | -0.11 | -0.15 | -0.19 | -0.25 | -0.18 | -0.3 | -0.28 | -0.4 | -0.35 | -0.17 | 0.59 | -0.19 | 0.14 | 0.04 | -0.06 | -0.07 | -0.03 | -0.043 | -0.1 | -0.03 | -0.04 | -0.053 | -0.07 | -0.07 | -0.07 | ||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 128,415 | 127,949 | 127,376 | 126,658 | 126,953 | 126,405 | 126,111 | 125,502 | 125,687 | 125,356 | 125,026 | 124,217 | 124,425 | 124,068 | 123,630 | 119,962 | 122,559 | 118,287 | 116,199 | 108,579 | 110,461 | 107,887 | 104,484 | 100,470 | 103,899 | 98,297 | 94,740 | 85,618 | 87,253 | 81,017 | 80,507 | 79,426 | 79,617 | 79,413 | 78,650 | 77,542 | 78,145 | 77,448 | 76,068 | 60,526 | ||||||||||||||||||||||||||||
diluted | 128,415 | 127,949 | 127,376 | 126,658 | 126,953 | 126,405 | 126,111 | 125,502 | 125,687 | 125,356 | 125,026 | 124,217 | 124,425 | 124,068 | 123,630 | 119,962 | 122,559 | 131,237 | 116,199 | 111,794 | 119,191 | 107,887 | 104,484 | 103,615 | 107,880 | 102,336 | 94,740 | 91,568 | 90,899 | 90,168 | 80,507 | 79,426 | 79,617 | 79,413 | 78,650 | 77,542 | 78,145 | 77,448 | 76,068 | 60,526 | ||||||||||||||||||||||||||||
clinical services | 105,426,500 | 145,783,000 | 141,388,000 | 134,535,000 | 130,058,000 | 127,553,000 | 123,156,000 | 114,869,000 | 108,166,000 | 106,162,000 | 105,635,000 | 98,791,000 | 104,053,000 | 102,227,000 | 101,405,000 | 96,487,000 | 106,738,000 | 108,733,000 | 73,884,000 | 92,982,000 | 93,404,000 | 92,565,000 | 88,982,000 | 86,210,000 | 65,913,000 | 59,449,000 | 59,540,000 | |||||||||||||||||||||||||||||||||||||||||
advanced diagnostics | 16,715,000 | 22,041,000 | 23,114,000 | 21,705,000 | 25,494,000 | 24,401,000 | 23,761,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total net revenue | 122,141,500 | 167,824,000 | 164,502,000 | 156,240,000 | 155,552,000 | 151,954,000 | 146,917,000 | 137,220,000 | 138,705,000 | 128,782,000 | 125,072,000 | 117,169,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
yoy | -21.48% | 10.44% | 11.97% | 13.86% | 12.15% | 17.99% | 17.47% | 17.11% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
qoq | -27.22% | 2.02% | 5.29% | 0.44% | 2.37% | 3.43% | 7.07% | -1.07% | 7.71% | 2.97% | 6.74% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pharma services | 22,351,000 | 30,539,000 | 22,620,000 | 19,437,000 | 18,378,000 | 21,679,000 | 19,113,000 | 20,319,000 | 19,046,000 | 19,259,000 | 16,711,000 | 13,093,000 | 13,048,000 | 13,464,000 | 12,107,000 | 12,731,000 | 9,367,000 | 10,562,000 | 9,647,000 | 8,206,000 | 6,452,000 | 8,713,000 | 6,866,000 | 6,299,000 | 4,986,000 | |||||||||||||||||||||||||||||||||||||||||||
gain on investment in and loan receivable from non-consolidated affiliate | -17,750,000 | -96,534,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustment to net income for convertible notes in diluted eps | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible note accretion, amortization, and interest, net of tax | 1,552,000 | 1,975,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income used in diluted eps | -35,303,000 | 8,353,000 | -20,348,000 | 77,425,000 | -2,811,250 | 4,532,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other incomes | -168,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax (benefit) expense | -3,753,000 | -7,850,000 | -335,000 | -11,132,000 | -2,023,000 | 438,000 | -134,750 | 340,000 | -54,000 | -825,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net revenue: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total revenue | 89,649,250 | 121,340,000 | 121,724,000 | 115,533,000 | 79,612,750 | 125,444,000 | 86,977,000 | 106,030,000 | 106,868,000 | 104,672,000 | 101,713,000 | 95,577,000 | 76,475,000 | 69,096,000 | 67,746,000 | 63,423,000 | 67,793,000 | 63,052,000 | 66,090,000 | 61,676,000 | 60,490,000 | 60,761,000 | 63,129,000 | 59,704,000 | ||||||||||||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | 1,400,000 | 1,018,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on termination of cash flow hedge | 3,506,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax expense | 976,000 | 332,000 | 174,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustment to the numerator for convertible notes in diluted eps | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deemed dividends on preferred stock and amortization of beneficial conversion feature | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on redemption of preferred stock | -9,075,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to common stockholders | 6,296,000 | 2,143,000 | 1,991,000 | -2,424,000 | 353,000 | 2,023,000 | 5,924,000 | -2,212,000 | 2,260,000 | -7,751,000 | -2,682,000 | -3,220,000 | -14,197,000 | -5,634,000 | -5,154,000 | -5,412,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
income per share attributable to common stockholders | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 0.06 | 0.02 | 0.02 | -0.03 | 0.018 | 0.02 | 0.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 0.06 | 0.02 | 0.02 | -0.03 | 0.015 | 0.02 | 0.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 128,415 | 127,949 | 127,376 | 126,658 | 126,953 | 126,405 | 126,111 | 125,502 | 125,687 | 125,356 | 125,026 | 124,217 | 124,425 | 124,068 | 123,630 | 119,962 | 122,559 | 118,287 | 116,199 | 108,579 | 110,461 | 107,887 | 104,484 | 100,470 | 103,899 | 98,297 | 94,740 | 85,618 | 87,253 | 81,017 | 80,507 | 79,426 | 79,617 | 79,413 | 78,650 | 77,542 | 78,145 | 77,448 | 76,068 | 60,526 | ||||||||||||||||||||||||||||
diluted | 128,415 | 127,949 | 127,376 | 126,658 | 126,953 | 126,405 | 126,111 | 125,502 | 125,687 | 125,356 | 125,026 | 124,217 | 124,425 | 124,068 | 123,630 | 119,962 | 122,559 | 131,237 | 116,199 | 111,794 | 119,191 | 107,887 | 104,484 | 103,615 | 107,880 | 102,336 | 94,740 | 91,568 | 90,899 | 90,168 | 80,507 | 79,426 | 79,617 | 79,413 | 78,650 | 77,542 | 78,145 | 77,448 | 76,068 | 60,526 | ||||||||||||||||||||||||||||
deemed dividends on preferred stock | 8,248,000 | 947,000 | 1,003,000 | 911,000 | 912,000 | 929,000 | 894,000 | 12,491,000 | 1,840,000 | 1,840,000 | 1,840,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of preferred stock beneficial conversion feature | -8,248,000 | 1,824,000 | 1,853,000 | 1,780,000 | 1,739,000 | 1,710,000 | 1,672,000 | -4,517,000 | 3,727,000 | 3,727,000 | 3,727,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of path logic | 1,058,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
clinical testing | 56,971,000 | 43,167,000 | 56,186,000 | 59,791,000 | 56,690,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gross margin | 27,196,000 | 27,257,000 | 27,345,000 | 28,605,000 | 27,173,000 | 12,228,000 | 11,171,000 | 10,813,000 | 9,544,000 | 8,709,000 | 7,246,000 | 7,144,000 | 3,865,000 | 4,074,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
clinical testing revenue | 41,668,500 | 55,739,000 | 56,316,000 | 54,622,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pharma services & research revenue | 4,229,750 | 5,022,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
biopharma & research revenue | 6,813,000 | 5,082,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and other income – net | -155,750 | -239,000 | -189,000 | 1,665,000 | -218,000 | -253,000 | -187,250 | -231,000 | -232,000 | -209,250 | -291,000 | -288,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income taxes | -260,500 | -125,000 | -161,000 | -756,000 | 129,000 | 20,000 | 603,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes | 5,000 | 15,000 | 5,000 | 79,000 | 51,000 | 27,000 | 106,000 | 29,000 | 17,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | -0.005 | 0 | 0 | -0.01 | -0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of shares outstanding – basic | 60,537 | 60,425 | 60,277 | 53,483 | 48,263 | 45,027,010 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of shares outstanding – diluted | 60,537 | 60,425 | 60,277 | 56,016 | 52,775 | 48,715,063 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and other income - net | 195,000 | -179,000 | -131,500 | -186,000 | -181,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- basic | 12,818 | -0.01 | 0.01 | 49,277 | 0.005 | 0.02 | 0.01 | 46,264 | 11,236 | -0.02 | 0.01 | -0.03 | -0.02 | -0.01 | 31,367,144 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
- diluted | 13,481.5 | -0.01 | 0.01 | 53,469 | 0.005 | 0.02 | 0.01 | 50,923 | 12,056.5 | -0.02 | 0.01 | -0.03 | -0.02 | -0.01 | 38,243,857 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted avg number of shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest income—net | -265,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest income - net | -285,000 | -258,000 | -182,000 | -159,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income before taxes | 44,500 | -975,000 | 551,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
– basic | 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
– diluted | 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income / (loss) from operations | 861,000 | -711,000 | -591,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit for income taxes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and other income — net | -136,250 | -185,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— basic and diluted | -0.008 | 43,103,707 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- basic and diluted | -0.01 | -0.02 | -0.02 | -0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— basic | -0.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— diluted | -0.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other operating expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of shares outstanding – basic and fully diluted | 31,400,947 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.